Eva Bubanská
Impact in
- Hematology top 10%
- Hemophilia Treatment and Research
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hemophilia Treatment and Research 2
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Raffaele Badolato (1 shared paper)Massimo Fiorilli (1 shared paper)Annarosa Soresina (1 shared paper)Rajesh Kumar (1 shared paper)Fulvio Porta (1 shared paper)Andrea Cecilia Gómez Raccio (1 shared paper)Vassilios Lougaris (1 shared paper)Alessandro Plebani (1 shared paper)
In The Last Decade
Eva Bubanská
18 papers receiving 292 citations
Peers
Comparison fields: 5 of 35
- Hematology 80
- Pathology and Forensic Medicine 77
- Immunology 62
- Public Health, Environmental and Occupational Health 38
- Genetics 27
Countries citing papers authored by Eva Bubanská
This map shows the geographic impact of Eva Bubanská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Bubanská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Bubanská more than expected).
Fields of papers citing papers by Eva Bubanská
This network shows the impact of papers produced by Eva Bubanská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Bubanská. The network helps show where Eva Bubanská may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Bubanská, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 63 | |
| 2 | 2015 | 49 | |
| 3 | 2019 | 45 | |
| 4 | 2016 | 42 | |
| 5 | 2021 | 26 | |
| 6 | 2019 | 13 | |
| 7 | 2016 | 12 | |
| 8 | 1993 | 7 | |
| 9 | 2010 | 7 | |
| 10 | 2011 | 7 | |
| 11 | 2012 | 7 | |
| 12 | 2009 | 4 | |
| 13 | Capizzi methotrexate with BFM backbone without craniospinalirradiation is effective treatment for pediatric lymphoblasticlymphoma: results from 5 countries with I-BFM LL 09 protocol | 2015 | 4 |
| 14 | 2019 | 4 | |
| 15 | Heart transplant in a childhood leukemia survivor: a case report. | 2010 | 3 |
| 16 | 2012 | 3 | |
| 17 | Non-anaplastic peripheral T-cell lymphoma in children and adolescents - International review | 2015 | 3 |
| 18 | 2015 | 1 |
About Eva Bubanská
Eva Bubanská is a scholar working on Hematology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Genetics and Infectious Diseases, having authored 18 papers that have together received 300 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Acute Myeloid Leukemia Research (3 papers), Hemophilia Treatment and Research (2 papers), Blood disorders and treatments (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Antifungal resistance and susceptibility (1 paper) and Protein Tyrosine Phosphatases (1 paper). The work is most often cited by research in Hematology (80 citations), Pathology and Forensic Medicine (77 citations), Immunology (62 citations), Public Health, Environmental and Occupational Health (38 citations) and Genetics (27 citations). Eva Bubanská has collaborated with scholars based in Slovakia, Czechia and Germany. Frequent co-authors include Raffaele Badolato, Massimo Fiorilli, Annarosa Soresina, Rajesh Kumar, Fulvio Porta, Andrea Cecilia Gómez Raccio, Vassilios Lougaris, Alessandro Plebani, Marcella Visentini and Laura Dotta. Their work appears in journals such as Chemotherapy, Haemophilia, The Journal of Allergy and Clinical Immunology In Practice, Haematologica and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.